We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+16.47%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$10.6B
AUM Growth
+$842M
Cap. Flow
-$440M
Cap. Flow %
-4.14%
Top 10 Hldgs %
16.26%
Holding
2,304
New
726
Increased
425
Reduced
494
Closed
615

Top Buys

Rank Stock Value
1
MCD icon
McDonald's
MCD
+$240M
2
TMO icon
Thermo Fisher Scientific
TMO
+$151M
3
BSX icon
Boston Scientific
BSX
+$121M
4
AMZN icon
Amazon
AMZN
+$104M
5
TRU icon
TransUnion
TRU
+$81M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 22.87%
2 Healthcare 20.58%
3 Financials 10.9%
4 Technology 10.13%
5 Industrials 8.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KTOS icon
1576
Kratos Defense & Security Solutions
KTOS
$8.88B
$35K ﹤0.01%
+2,241
New +$35.3K
UPBD icon
1577
Upbound Group
UPBD
$1.19B
$35K ﹤0.01%
1,692
-968,659
-100% -$17.9M
INFI
1578
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$35K ﹤0.01%
18,606
-24,065
-56% -$35.2K
HLI icon
1579
Houlihan Lokey
HLI
$9.68B
$34K ﹤0.01%
746
-42,200
-98% -$1.86M
KB icon
1580
KB Financial Group
KB
$41.2B
$34K ﹤0.01%
+931
New +$37.2K
PBH icon
1581
Prestige Consumer Healthcare
PBH
$2.35B
$34K ﹤0.01%
1,149
PDD icon
1582
Pinduoduo
PDD
$118B
$34K ﹤0.01%
1,382
-9,366
-87% -$251K
RST
1583
DELISTED
ROSETTA STONE INC
RST
$34K ﹤0.01%
+1,538
New +$26.8K
APVO icon
1584
Aptevo Therapeutics
APVO
$5.47M
0
WPP icon
1585
WPP
WPP
$4.04B
$33K ﹤0.01%
625
-25,346
-98% -$1.41M
GHL
1586
DELISTED
Greenhill & Co., Inc.
GHL
$33K ﹤0.01%
1,512
-45,326
-97% -$1.13M
CF icon
1587
CF Industries
CF
$19.2B
$32K ﹤0.01%
773
-12,449
-94% -$528K
EPP icon
1588
iShares MSCI Pacific ex Japan ETF
EPP
$2.18B
$32K ﹤0.01%
+700
New +$31K
LQDA icon
1589
Liquidia Corp
LQDA
$7.67B
$32K ﹤0.01%
+2,798
New +$44.8K
BKR icon
1590
Baker Hughes
BKR
$56.8B
$31K ﹤0.01%
1,107
-75,842
-99% -$1.92M
ROK icon
1591
Rockwell Automation
ROK
$51.4B
$31K ﹤0.01%
179
-159,196
-100% -$27.1M
USPH icon
1592
US Physical Therapy
USPH
$1.14B
$31K ﹤0.01%
292
-320
-52% -$34.4K
VTRS icon
1593
Viatris
VTRS
$20.1B
$31K ﹤0.01%
1,081
CLB icon
1594
Core Laboratories
CLB
$538M
$30K ﹤0.01%
+433
New +$29K
FNV icon
1595
Franco-Nevada
FNV
$41.4B
$30K ﹤0.01%
400
-18,932
-98% -$1.41M
NAK
1596
Northern Dynasty Minerals
NAK
$885M
$30K ﹤0.01%
+50,175
New +$39.2K
NLY icon
1597
Annaly Capital Management
NLY
$16.9B
$30K ﹤0.01%
+754
New +$30.8K
HLG
1598
DELISTED
Hailiang Education Group Inc. American Depositary Shares
HLG
$30K ﹤0.01%
784
-3,009
-79% -$115K
CBM
1599
DELISTED
Cambrex Corporation
CBM
$30K ﹤0.01%
+780
New +$31.9K
ALNT icon
1600
Allient
ALNT
$1.47B
$29K ﹤0.01%
+1,275
New +$35.3K

Similar funds

Marshall Wace's Q1 2019 Portfolio in Review

As of Q1 2019, Marshall Wace held 2,304 positions worth $10.6B, up 8.6% from $9.8B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Marshall Wace withdrew a net $440M in Q1 2019, closing 615 positions and reducing 494 holdings. Its most notable exit was Shire pic, an estimated $166M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 23% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Marshall Wace opened a new position in TransUnion worth $87.4M.

  • Marshall Wace's largest Q1 2019 buy was TransUnion: 1,307,679 shares worth $87.4M.
  • Marshall Wace added most to McDonald's in Q1 2019, an estimated $240M increase.
  • Marshall Wace's biggest Q1 2019 reduction was Alphabet (Google) Class A, cutting an estimated $132M.
  • Marshall Wace fully exited Shire pic in Q1 2019, selling an estimated $166M.
  • Marshall Wace's ten largest holdings make up 16% of its $10.6B portfolio in Q1 2019.
  • Marshall Wace opened 726 new positions and closed 615 in Q1 2019.
  • Marshall Wace's portfolio value rose 8.6% quarter-over-quarter to $10.6B.

Based on Marshall Wace's 13F filing for Q1 2019, filed 14 May 2019.